Prashant Patel - 01 Sep 2022 Form 4 Insider Report for TRxADE HEALTH, INC (SCNX)

Role: President and COO, Director, 10%+ Owner
Signature: /s/ Prashant Patel
Issuer symbol: SCNX
Transactions as of: 01 Sep 2022
Net transactions value: $0
Form type: 4
Filing time: 16 Sep 2022, 17:20:16 UTC
Next filing: 16 Jan 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MEDS	Common stock	Award	$0	+8,620	+0.69%	$0.000000	1,261,120	01 Sep 2022	Direct	F1, F2
holding	MEDS	Common stock						400,000	01 Sep 2022	Through Patel Trust 2010 which Reporting Person controls as trustee
holding	MEDS	Common stock						416,667	01 Sep 2022	Through spouse

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares of Restricted Common Stock were issued to the Reporting Person pursuant to the Issuer's Amended and Restated 2019 Equity Incentive Plan and are subject to forfeiture. The shares vest at the rate of 1/4 of the shares on September 30, 2022, October 31, 2022, November 30, 2022 and December 31, 2022, subject to the Reporting Person's continued service to the Company on such vesting dates, and subject to the terms and conditions of a Restricted Shares Grant Agreement entered into by and between the Issuer and the Reporting Person. Exempt under Rule 16b-3(d).
F2	Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as President and Chief Operating Officer.

Content

Shares of Restricted Common Stock were issued to the Reporting Person pursuant to the Issuer's Amended and Restated 2019 Equity Incentive Plan and are subject to forfeiture. The shares vest at the rate of 1/4 of the shares on September 30, 2022, October 31, 2022, November 30, 2022 and December 31, 2022, subject to the Reporting Person's continued service to the Company on such vesting dates, and subject to the terms and conditions of a Restricted Shares Grant Agreement entered into by and between the Issuer and the Reporting Person. Exempt under Rule 16b-3(d).

Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as President and Chief Operating Officer.